"Ousted vaccine chief warns window is closing to address pandemic, says federal government has no coronavirus plan" By Liz Goodwin Globe Staff, May 14, 2020
WASHINGTON — The nation’s former top vaccine official warned Thursday that dysfunction in the federal government may lead to the “darkest winter in history” if the Trump administration does not quickly implement a comprehensive plan to combat coronavirus.
"The window is closing to address this pandemic because we still do not have a standard, centralized, coordinated plan to take this nation through this response,” said Dr. Rick Bright, the former director of the Biomedical Advanced Research and Development Authority, who was removed from his post last month and has filed a whistle-blower complaint.
Related:
Thanks to the source of the video, and I have backed it up on bitchute just in case.
The end of civilization is no fairy tale and that is why I am in such distress.
Testifying at a House hearing, Bright also questioned the 12-18 month timeline for a vaccine proposed by the Trump administration, which would require everything to go “perfectly.” He noted that vaccines can take up to 10 years to develop.
Bright’s testimony painted a bleak picture of a federal government that failed to adequately prepare for the pandemic and is still missing opportunities to obtain materials necessary for mass distribution of a vaccine and protecting health care workers ahead of a possible resurgence of cases in the fall.
You can bet on the second wave right before kickoff; that's what the simulation calls for, and Trump says one will be ready by the end of the year.
That failure to prepare cost lives, Bright acknowledged, and the US death toll of 84,000 as of Thursday would likely be lower if scientists’ warnings were heeded. “Initially our nation was not as prepared as we should have been, as we could have been," he said. "Some scientists that raised early warning signals were overlooked.”
He also warned that the administration lacked a plan “to fairly and equitably distribute” the only drug that has shown some effectiveness in treating coronavirus thus far, remdesivir, and still did not have a comprehensive testing plan. “We don’t have a single point of leadership right now for this response and we don’t have a master plan for this response,” Bright said.
The hearing followed testimony Tuesday by the nation’s top infectious disease expert, Dr. Anthony Fauci, who warned of “suffering and death” to come if states lift distancing regulations before seeing a sustained decrease in cases. The tone of both hearings sharply clashed with the upbeat message promulgated by President Trump, who has said that the country has “prevailed” on testing and that the virus will “go away" even without a vaccine.
He went over like cold porridge.
Trump criticized Bright to reporters at the White House before departing for a trip to Allentown, Pa., to tour a medical supply facility. “I watched this guy for a little while this morning,” he said. “I’ll tell you what, to me he’s nothing more than a really disgruntled, unhappy person.” He criticized Fauci for his testimony, as well, saying on Wednesday it was unacceptable that Fauci urged caution in opening schools..
The president, repeating his frequent boast despite ongoing criticism, said his administration has done “a great job” in responding to the pandemic.
That's because Jared has been put in charge.
Bright testified that his repeated warnings to stock up on masks and other crucial supplies to battle the virus were met with “indifference” and “excuses” when he began sounding the alarm in mid-January. He said that Health and Human Services Secretary Alex Azar and Centers for Disease Control Director Robert Redfield ignored his request for virus samples from China in January, slowing the development of treatments and vaccines.
Redfield wanted a relapse, and then he came down with COVID.
Bright, an immunologist who rose through the ranks of the federal agency after he joined in 2010, was reassigned to a lower-level role in the government after he resisted the administration’s push to widely distribute the malaria drug hydroxychloroquine in late March. The drug was not proven safe or effective to treat coronavirus, Bright argued. He was given a less important role in the National Institutes of Health in April. Trump again touted the supposed benefits of hydroxychloroquine on Thursday, which studies have not shown to be effective in treating the virus.
Related:
President Trump said on Monday that he was taking hydroxychloroquine. The drug has not been shown to combat the coronavirus in a multitude of studies (Doug Mills/Getty Images/pool/Getty Images).
There he goes again, reassuring the Satanists with his hand gesture!
“We have the world’s greatest scientists, let us lead,” Bright testified to the room full of masked lawmakers on a House Energy and Commerce subcommittee, flanked by a bottle of Lysol wipes. “Let us speak without fear of retribution.”
As long as that applies to all of us.
Some Republicans on the panel asked why Bright did not go to the Health and Human Services Department inspector general or bring his concerns to Congress earlier, while others questioned why he did not personally raise concerns about the lack of adequate masks before January.
The soft-spoken Bright defended himself calmly, and revealed he was being treated for high blood pressure due to the stress of losing his job and becoming a whistle-blower. Later, mask manufacturer Mike Bowen, who testified after Bright about the mask shortage problem, defended the doctor.
“I’m a Republican. I voted for President Trump and I admire Dr. Bright,” Bowen testified. “I believe him.”
Bright said his lowest moment over the past few months was when Bowen, executive vice president of Prestige Ameritech in Texas, contacted him in January to warn that the US N95 mask supply was “decimated" as the virus began traveling the globe.
“He said, ‘We are in deep shit,’ ” Bright said. The immunologist told HHS leadership of his concerns about the masks but “got no response.”
I was STUNNED when I an EXPLETIVE PRINTED in the PAPER!
They are "sinking" to my level!
“I knew that we were going to have a crisis for our health care workers because we were not taking action,” Bright recalled. “That was our last window of opportunity to turn on that production to save the lives of those health care workers and we didn’t act.”
In between the Last Supper reenactments and dance videos?
He testified that he finally found a sympathetic ear in the White House in the form of trade adviser Peter Navarro, who distributed a memo urging the government to produce more masks in February after speaking with Bright, but orders for protective equipment were still not placed until March, he said.
The administration pushed back on Bright’s claim that he was demoted in retaliation for his objection to widely distributing hydroxychloroquine, saying in a statement that he was transferred to lead “a bold new $1 billion testing program at NIH, critical to saving lives and reopening America.”
“Rick Bright’s assumption that others were not concerned with and working on various workstreams related to COVID-19 preparedness is bizarre and false,” HHS said in a statement Thursday, but the federal whistle-blower agency made a preliminary determination this month that there was a “substantial likelihood of wrongdoing” in Bright’s reassignment.
Bowen testified later on Thursday that his offer to make millions more N95 masks at his Texas factory in January was rejected. “I’m angry because I’ve done this for so long and I’ve been ignored for so long,” he said. “We could have protected America’s health care workers and patients."
Then there is an ulterior motive here?
--more--"
The Globe says the whistle-blower lays bare the incompetence that cost lives, and that his description of the White House response to the coronavirus pandemic is damning.
Of course there are "good" whistleblowers -- Vindman and the other Ukraine puke -- and "bad" whistleblowers like Assange, Snowden, Manning, the OPCW investigators, et al.
Related:
Donald Trump is planning to RESUME US funding for the WHO
He must have reversed himself again.
Trump Appoints Big Pharma Exec Connected to Bill Gates to Head Vaccine Developments
Trump’s WARP SPEED vaccine czar oversaw an infamously BOTCHED vaccination
Trump Regime Hazardous to Human Health Operation Warp Speed for Mass Vaxxing
Coronavirus Gives a Dangerous Boost to DARPA’s Darkest Agenda
Coronavirus: What Newsweek Failed to Mention About “Continuity of Government”
US Intel Agencies Played Unsettling Role in Classified and “9/11-like” Coronavirus Response Plan
From Anthrax To Coronavirus: Same 9/11 False Flag Players, New COVID-19 Boogeyman
Techno-Tyranny: How the US National Security State Is Using Coronavirus To Fulfill an Orwellian Vision
The barcode of the Beast means all roads lead to a Dark Winter -- or even worse, to Project Zyphr.
Unle$$ there is a cure:
"Scientists say the best treatment for COVID-19 may be a cocktail of medicines" by Jonathan Saltzman Globe Staff, May 14 2020
More than a dozen drug firms in Massachusetts are urgently searching for a medicine to treat COVID-19, but the most potent therapy may not end up being a single medication. Instead, medical experts say, the most effective way to battle the disease will likely be a combination of drugs taken together.
Cha-Ching!
Who needs a vaccine?
Two weeks after the federal government allowed hospitalized coronavirus patients to receive an experimental drug that provided only modest benefits, scientists say it increasingly appears the best treatment will be a cocktail of medicines similar to those used for other deadly infectious diseases, from tuberculosis to AIDS.
The need to develop drugs that can dramatically lessen symptoms of COVID-19 is especially crucial because a vaccine that could prevent the disease likely remains a year or more away.
Trump said they would have it by the end of the year, and I believe they already have it ready to go. They can't say they have it ready to go, though. That would blow the operation.
Dr. Barry Bloom, a professor at the Harvard T.H. Chan School of Public Health, said he’s optimistic that one or more medicines better than remdesivir — the experimental Gilead Sciences drug cleared for “emergency use" on May 1 ― will be available by the year’s end, but he expects the standard of care will probably evolve and ultimately rely on a combination of drugs that pass muster in clinical trials. “You don’t need only one drug,” said Bloom, a pioneer in global health who devoted much of his career to treating tuberculosis. “What we learned with HIV is that no one drug works very well, but if you put three drugs together that are pretty good drugs, you can control the virus for life.”
Just keep it quiet, will ya'?
How many people died from tuberculosis last year, and why wasn't the society locked down then?
Bloom and other experts suspect that unlike people with HIV, COVID-19 patients would require only short-term treatment with a combination of medicines and recover faster if they got them soon after symptoms appear.
A study published last Friday in Lancet, the respected medical journal, bolsters that notion. It found that patients with mild to moderate COVID-19 at six public hospitals in Hong Kong and the University of Hong Kong seemed to improve more quickly if treated with a three-drug combo, compared with a group that received a two-drug treatment. The triple combination featured three antiviral drugs: one used for HIV, another for hepatitis C, and a third for multiple sclerosis.
$$$$$$$$!
The federal website ClinicalTrials.gov lists more than 1,400 clinical trials related to COVID-19 planned or started around the world. A number of them involve combinations of approved and experimental drugs, including remdesivir.
Massachusetts General Hospital, which participated in the global trial of 1,063 coronavirus patients that led to the emergency use of remdesivir, plans to participate in a follow-up study that combines that antiviral medicine with another drug. That second drug is sold under the brand name Olumiant by Eli Lilly and is used to treat rheumatoid arthritis.
Dr. Libby Hohmann, principal investigator of the remdesivir trial at Mass. General, said the Gilead drug “had a real statistically significant effect, but as a lot of people are saying, it’s not a magic bullet or home run.” That’s why it makes sense to try to combine it with something else, she said.
The que$tion is, what will they price it at and what will be the benefit for the company.
Patients who received remdesivir had a 31 percent faster recovery than those who got a placebo, according to the National Institute of Allergy and Infectious Diseases, which ran the trial at 68 sites worldwide. The median recovery time was 11 days for patients who received remdesivir compared with 15 days for those who got a placebo.
Most researchers predict it will take a vaccine to end the pandemic and don’t expect one to be approved and deployed for 12 to 18 months, in the most optimistic scenario. As a result, researchers around the world are studying more than 200 experimental treatments to help sick patients recover, according to a tracker by the Milken Institute, a Santa Monica, Calif.-based think tank.
Deployed?
Like a weapon in war?
At least 15 drug companies based in Massachusetts or with an outpost in the state are studying possible treatments, as are local academic laboratories.
The firms include the Japanese drug giant Takeda Pharmaceutical, which is working with multiple partners on a drug made from the plasma of people who recovered from disease; Cambridge-based Alnylam Pharmaceuticals, which is collaborating with a San Francisco biotech on technology to silence the genes in the virus that causes COVID-19; and Sarepta Therapeutics, a Cambridge biotech collaborating with the Defense Department on an RNA-based treatment.
The DoD is in on the altering of our DNA, huh?
Akshay Vaishnaw, who heads research and development at Alnylam, said his company and Vir Biotechnology hope to begin testing an inhaled medicine in humans around the end of the year. The partners will first see how the drug performs by itself, he said, but it would hardly be surprising if researchers ended up studying it as part of a combination treatment. “Combinations allow multiple lines of attack on the pathogen,” Vaishnaw said.
Ultimately, researchers say, the standard of care may encompass a cocktail of antiviral drugs that use multiple targets, or it may be several different types of medicines, such as antiviral medicines and anti-inflammatory therapies.
"Infections between a virus and a host cell are complicated processes that involve many different steps,” said Dr. Joseph Loscalzo, head of the department of medicine at Brigham and Women’s Hospital. “That, coupled with the fact that these viruses can mutate quickly, would argue that combinations would help optimize the chance for a cure.”
So there may NEVER be an EFFECTIVE VACCINE, huh?
Loscalzo coauthored a recent study that ranked more than 80 approved drugs for their potential to work against COVID-19. The researchers used artificial intelligence and other tools to screen over 7,000 medications now used to treat other conditions.
The National Emerging Infectious Diseases Laboratories at Boston University is testing the roughly 80 drugs on cells from monkeys and humans infected with the coronavirus, and scientists there expect to have results soon.
Although combining drugs holds promise, it can also pose risks, Loscalzo said.
“Now you have to look at not just the toxicities of each drug, but the drugs when used in combination,” he said. “The [clinical] trial duration would likely be about the same, but getting to the point where you could, in a safe way, begin the trial requires more homework beforehand.”
Some scientists say they would prefer to repurpose a medicine that has been approved by the Food and Drug Administration for another disease rather than develop a new drug and test it in clinical trials, which can take years.
With all the drugs being studied, said Bloom, the public health expert from Harvard, it’s likely that data will emerge in the next couple of months about medicines that are better than remdesivir, but, he said, it’s premature to bet on any single drug or mix.
Like combination drugs marketed for HIV, he added, an effective cocktail might also become a medicine that doctors could prescribe as a preventative to patients who are at high risk for catching COVID-19. Gilead, which makes remdesivir, sells such a “pre-exposure prophylaxis," or PrEP, to prevent HIV. The product, marketed as Truvada, combines two medications.
“A drug that you could give to healthy people who would be exposed ― that would be a new and appealing preventative therapy," Bloom said.
--more--"
If it averts this guys agenda I'm all for it:
"James Corbett: Bill Gates & The Population Control Grid
James Corbett: Episode 379 – Bill Gates and the Population Control Grid
This is the third episode in a continuing series.. You can see them at Corbett's site or relinked below
Part 1: How Bill Gates Monopolozed Global Health Equals Why Justin Trudeau "Thanks" Bill and Melinda Gates
Part 2: James Corbett: Bill Gates' Plan To Vaccinate the Globe
This is the third episode in a continuing series.. You can see them at Corbett's site or relinked below
Part 1: How Bill Gates Monopolozed Global Health Equals Why Justin Trudeau "Thanks" Bill and Melinda Gates
Part 2: James Corbett: Bill Gates' Plan To Vaccinate the Globe
The takeover of public health that we have documented in How Bill Gates Monopolized Global Health and the remarkably brazen push to vaccinate everyone on the planet that we have documented in Bill Gates’ Plan to Vaccinate the World was not, at base, about money. The unimaginable wealth that Gates has accrued is now being used to purchase something much more useful: control. Control not just of the global health bodies that can coordinate a worldwide vaccination program, or the governments that will mandate such an unprecedented campaign, but control over the global population itself.
